Gilead’s “Generic Drug” Launch – Competitive Strategy 101
Gilead’s “Generic Drug” Launch – Competitive Strategy 101 Gilead Sciences announced it will begin selling…
Pharmaceutical Market Strategies
Gilead’s “Generic Drug” Launch – Competitive Strategy 101 Gilead Sciences announced it will begin selling…
This has been on my mind since last Thursday after an advisor to my research…
Last week we published a literature review of economic models published on new hepatitis C…
Recently, I had the opportunity to work with two strong pharmacoeconomics researchers (Daniel Mullins and…
Over the next few years, my career will shift focus to pharmacoeconomics (#PharmEcon) research and…
It was announced this week that the Food and Drug Administration (FDA) has officially approved…
On December 22, 2014 Express Scripts (ESRX) announced to the public that it had reached…